ONCOLOGY SOLUTIONS

Precision cancer care for improved outcomes at every step of the care pathway.

The fight against cancer is a daunting one. With the incidence of cancer expected to rise sharply worldwide, coupled with nearly half of cancer diagnoses arriving too late, cancer care providers need to utilize every advantage available to them. GE Healthcare oncology solutions are designed to help cancer care providers to gain the upper hand with an innovative suite of diagnostic and treatment technologies designed to help improve detection, clinical efficiency, operational efficiency, and outcomes. In short, to help cancer care providers provide perhaps the most important prognosis of all: hope.

Oncology Pathways

Lung Cancer

Lung Cancer is the leading cause of cancer deaths around the world, causing more deaths than prostate, breast and colon cancer combined.¹ Only 18.5 percent of patients will survive five or more years after being diagnosed with lung cancer.²
Reinforcing the National Lung Cancer Screening Trail’s (NLST)³, the Nelson study provided promising new results that annual screening of high risk patients using low dose CT had a 26 percent mortality reduction in the male trial.^4,5 GE Healthcare provides high quality CT scanners for the new low dose lung cancer screening option.⁶

Breast Cancer

Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year. According to the WHO, it is estimated that 627,000 women died from breast cancer in 2018 which represents 15 percent of all cancer deaths among women.¹

Colorectal Cancer

The global burden of colorectal cancer (CRC) is expected to increase by 60 percent to more than 2.2 million new cases and 1.1 million deaths by 2030.¹ Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States.

Hematological Malignancies

In 2016, 467,000 new cases of leukemia and 310,000 deaths were reported. One in 118 men will develop the disease compared with one in 194 women. The main contributors to this increase were population growth with 12 percent, population aging with 10 percent, and an increase in age-specific incidence rates with 3 percent.¹

Liver Cancer

Liver cancer is the fifth most common cancer, accounting for 8.2 percent of all cancer deaths worldwide.¹ The incidence is rising across all continents including in the United States. A study published in JAMA Oncology, December 2017 found the incidence of liver cancer increased by 75 percent worldwide between 1990 and 2015.² Effective surveillance programs with imaging could offer early diagnosis and provide an opportunity for better treatment options.

Lung Cancer

Lung Cancer is the leading cause of cancer deaths around the world, causing more deaths than prostate, breast and colon cancer combined.¹ Only 18.5 percent of patients will survive five or more years after being diagnosed with lung cancer.²
Reinforcing the National Lung Cancer Screening Trail’s (NLST)³, the Nelson study provided promising new results that annual screening of high risk patients using low dose CT had a 26 percent mortality reduction in the male trial.^4,5 GE Healthcare provides high quality CT scanners for the new low dose lung cancer screening option.⁶

Liver Cancer

Liver cancer is the fifth most common cancer, accounting for 8.2 percent of all cancer deaths worldwide.¹ The incidence is rising across all continents including in the United States. A study published in JAMA Oncology, December 2017 found the incidence of liver cancer increased by 75 percent worldwide between 1990 and 2015.² Effective surveillance programs with imaging could offer early diagnosis and provide an opportunity for better treatment options.

Lung Cancer

Lung Cancer is the leading cause of cancer deaths around the world, causing more deaths than prostate, breast and colon cancer combined.¹ Only 18.5 percent of patients will survive five or more years after being diagnosed with lung cancer.²
Reinforcing the National Lung Cancer Screening Trail’s (NLST)³, the Nelson study provided promising new results that annual screening of high risk patients using low dose CT had a 26 percent mortality reduction in the male trial.^4,5 GE Healthcare provides high quality CT scanners for the new low dose lung cancer screening option.⁶

The latest in Oncology

What Does Precision Cancer Care Mean to You?
Perhaps it’s as simple as improved clinical detection, or real-time data sharing?

Whatever your definition of precision cancer care is, we know the end goal is always the best possible outcome for your patients. For this reason, GE supports cancer centers and hospitals all over the world to help improve cancer care from screening to treatment through advanced medical technologies, providing physicians and technicians with greater clinical insights. We work with you to address your specific clinical and operational challenges to achieve the best possible patient outcome through the most precise treatment available.

References: